Alzheimer Disease: all 3,765 studies

Page 13 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.

• A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT03019536Phase 1Results posted
• Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease DementiaCompletedNCT03001557Phase 2Results posted
• Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)TerminatedNCT02992132Phase 2Results posted
• A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.CompletedNCT02989402Phase 4Results posted
• A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease DementiaTerminatedNCT02972658Phase 3Results posted
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseTerminatedNCT02956486Phase 3Results posted
• Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's DiseaseCompletedNCT02947893Phase 2Results posted
• Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's DiseaseCompletedNCT02925650Phase 1/2Results posted
• 2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)TerminatedNCT02916056Phase 3Results posted
• An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)CompletedNCT02910739Phase 1Results posted
• Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With DementiaCompletedNCT02910102Phase 2Results posted
• A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular DementiaCompletedNCT02886494Phase 2Results posted
• Imaging Tau in Alzheimer's Disease and Normal AgingTerminatedNCT02884492Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseCompletedNCT02880956Phase 2Results posted
• The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic ExpressionCompletedNCT02849639Early Phase 1Results posted
• Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility StudyCompletedNCT02846415Not applicableResults posted
• Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)CompletedNCT02843529Not applicableResults posted
• Imaging Inflammation in Alzheimer's DiseaseCompletedNCT02831283Phase 2Results posted
• ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's DiseaseTerminatedNCT02817906Phase 3Results posted
• Comparison of PET Amyloid Imaging in Japanese and Western SubjectsCompletedNCT02813070Phase 2Results posted
• Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05CompletedNCT02795780Phase 2Results posted
• Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's DiseaseCompletedNCT02792257Phase 2Results posted
• A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease DementiaTerminatedNCT02791191Phase 2Results posted
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02788513Phase 2Results posted
• Safety and Efficacy of Donepezil in Mild to Moderate Alzheimer's DiseaseCompletedNCT02787746Phase 4Results posted
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaTerminatedNCT02783573Phase 3Results posted
• Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTerminatedNCT02769065Phase 1Results posted
• Low Dose RT to Reduce Cerebral Amyloidosis in Early Alzheimer'sTerminatedNCT02769000Not applicableResults posted
• Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance ImagingCompletedNCT02767609Not applicableResults posted
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseTerminatedNCT02760602Phase 3Results posted
• A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)CompletedNCT02754830Phase 1Results posted
• Safety and Efficacy of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Alzheimer's Disease (MK-4305-061)CompletedNCT02750306Phase 3Results posted
• A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)CompletedNCT02727699Phase 2Results posted
• Memory Improvement Through Nicotine Dosing (MIND) StudyCompletedNCT02720445Phase 2Results posted
• Triggered Palliative Care for Advanced DementiaCompletedNCT02719938Not applicableResults posted
• Brain Amyloid and Vascular Effects of Eicosapentaenoic AcidCompletedNCT02719327Phase 2/3Results posted
• Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's DiseaseCompletedNCT02708485Not applicableResults posted
• Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)CompletedNCT02708186Phase 2Results posted
• NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.CompletedNCT02703636Phase 4Results posted
• Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT02702102Phase 2Results posted
• Monetary Cost of Alzheimer's Disease in ChinaCompletedNCT02694445Results posted
• Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With ADCompletedNCT02681172Phase 4Results posted
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).TerminatedNCT02670083Phase 3Results posted
• Candesartan's Effects on Alzheimer's Disease And Related BiomarkersCompletedNCT02646982Phase 2Results posted
• A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADCompletedNCT02624778Phase 1Results posted
• [11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)CompletedNCT02621606Phase 1Results posted
• Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)CompletedNCT02615002Phase 2Results posted
• A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)TerminatedNCT02614131Phase 1Results posted
• Pragmatic Trial of Video Education in Nursing HomesCompletedNCT02612688Not applicableResults posted
• Trial of Oxaloacetate in Alzheimer's Disease (TOAD)CompletedNCT02593318Phase 1Results posted
• 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET ExtensionTerminatedNCT02586909Phase 3Results posted
• Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyCompletedNCT02585934Phase 3Results posted
• Optimizing Dementia CareCompletedNCT02585232Not applicableResults posted
• SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a StudyCompletedNCT02580305Phase 2Results posted
• Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of AgeCompletedNCT02576639Phase 2Results posted
• An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's DementiaTerminatedNCT02569398Phase 2/3Results posted
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseTerminatedNCT02565511Phase 2/3Results posted
• [18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)CompletedNCT02562989Phase 1Results posted
• Feasibility Study in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT02560753Phase 1/2Results posted
• Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With AlzheimerCompletedNCT02553928Phase 4Results posted
• Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) PatientsCompletedNCT02551809Phase 2Results posted
• A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's TypeCompletedNCT02549196Phase 2Results posted
• 18F-AV-1451 Autopsy StudyCompletedNCT02516046Phase 3Results posted
• Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's DiseaseTerminatedNCT02503501Phase 2Results posted
• Webnovela for Hispanic Dementia Family CaregiversCompletedNCT02489110Not applicableResults posted
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseTerminatedNCT02484547Phase 3Results posted
• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseTerminatedNCT02477800Phase 3Results posted
• Health Evaluation in African Americans Using RAS TherapyCompletedNCT02471833Phase 1/2Results posted
• New Approach for Treatment of Behavioral Disorders in Alzheimer's Disease (Alzheimer's Behavioral and Cognitive Disorders)CompletedNCT02462291Not applicableResults posted
• Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain FunctionCompletedNCT02460783Not applicableResults posted
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's TypeCompletedNCT02442778Phase 3Results posted
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeCompletedNCT02442765Phase 3Results posted
• A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's DiseaseCompletedNCT02431468Phase 2Results posted
• Clinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADCompletedNCT02423200Phase 2Results posted
• A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer's Disease (AD)CompletedNCT02423122Phase 2Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease SpectrumTerminatedNCT02406027Phase 2Results posted
• Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy VolunteersCompletedNCT02392468Phase 1Results posted
• aeRobic Exercise and Cognitive HealthCompletedNCT02384993Not applicableResults posted
• Aggression Prevention Training for Caregivers of Persons With Dementia (APT)CompletedNCT02380703Not applicableResults posted
• Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's DiseaseCompletedNCT02380573Phase 2Results posted
• Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's DiseaseTerminatedNCT02359864Not applicableResults posted
• Rasagiline Rescue in Alzheimer's Disease Clinical TrialCompletedNCT02359552Phase 2Results posted
• 18F-AV-1451 High Resolution Autopsy StudyCompletedNCT02350634Phase 1Results posted
• Preventing Loss of Independence Through Exercise (PLIE) in Persons With DementiaCompletedNCT02350127Phase 2/3Results posted
• Apathy in Dementia Methylphenidate Trial 2CompletedNCT02346201Phase 3Results posted
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02337907Phase 2Results posted
• Augmenting Flortaucipir Dosimetry EstimatesCompletedNCT02336360Phase 1Results posted
• A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's DiseaseCompletedNCT02323334Phase 1Results posted
• I2PETHV - Imidazoline2 Binding Site in Healthy VolunteersCompletedNCT02323217Early Phase 1Results posted
• Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's DiseaseTerminatedNCT02322021Phase 2Results posted
• Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.CompletedNCT02309723Not applicableResults posted
• Benfotiamine in Alzheimer's Disease: A Pilot StudyCompletedNCT02292238Phase 2Results posted
• AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseTerminatedNCT02284906Phase 3Results posted
• Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2Results posted
• Tau Imaging in Professional FightersCompletedNCT02278354Phase 1Results posted
• An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's DiseaseTerminatedNCT02245737Phase 2/3Results posted
• Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)TerminatedNCT02245568Phase 3Results posted
• Alzheimer Disease Proof of Concept Study With BI 409306 Versus PlaceboCompletedNCT02240693Phase 2Results posted
• Impact of Pharmacotherapy Management in Patients With Alzheimer's DiseaseCompletedNCT02222181Not applicableResults posted
• Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's DiseaseTerminatedNCT02221947Phase 1/2Results posted

← Alzheimer Disease overview